Maxigen Biotech Inc
TWSE:1783

Watchlist Manager
Maxigen Biotech Inc Logo
Maxigen Biotech Inc
TWSE:1783
Watchlist
Price: 41.9 TWD 0.12% Market Closed
Market Cap: 3.7B TWD
Have any thoughts about
Maxigen Biotech Inc?
Write Note

Maxigen Biotech Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Maxigen Biotech Inc
Operating Expenses Peer Comparison

Comparables:
G
1707
1731
4137

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Maxigen Biotech Inc
TWSE:1783
Operating Expenses
-NT$290.2m
CAGR 3-Years
-22%
CAGR 5-Years
-14%
CAGR 10-Years
-10%
G
Grape King Bio Ltd
TWSE:1707
Operating Expenses
-NT$6B
CAGR 3-Years
-4%
CAGR 5-Years
-3%
CAGR 10-Years
-5%
Maywufa Co Ltd
TWSE:1731
Operating Expenses
-NT$710.5m
CAGR 3-Years
-8%
CAGR 5-Years
-6%
CAGR 10-Years
-5%
Chlitina Holding Ltd
TWSE:4137
Operating Expenses
-NT$2.7B
CAGR 3-Years
-2%
CAGR 5-Years
-2%
CAGR 10-Years
-6%

See Also

What is Maxigen Biotech Inc's Operating Expenses?
Operating Expenses
-290.2m TWD

Based on the financial report for Jun 30, 2024, Maxigen Biotech Inc's Operating Expenses amounts to -290.2m TWD.

What is Maxigen Biotech Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-10%

Over the last year, the Operating Expenses growth was -16%. The average annual Operating Expenses growth rates for Maxigen Biotech Inc have been -22% over the past three years , -14% over the past five years , and -10% over the past ten years .

Back to Top